Market size- Industry Trends & Outlook Report 2026
Global Transplantation Market worth was estimated at USD 13.7 billion in 2019, and it is expected to reach USD 24.09 billion by 2026 at a CAGR of 8.4% during the projection period. The Global Transplantation Market thrives on the need for organ transplants and the demand for tissue products, immunosuppressant drugs, and organ preservation. Technological advancements further support market growth. The high success rate of transplantation enhances the demand for tissue and organ transplantation services. A large part of the global population suffers from different diseases such as diabetes, cardiovascular disease, pulmonary diseases, cancer, or renal diseases, leading to organ and tissue failure requiring transplantation. The market players provide organ and tissue procurement and preservation for meeting the requirement of transplantation. Rising regulatory approvals for innovative products and new guidelines for organ donations also improve market prospects. However, market growth is impeded by limited organ supply, organ rejection, and high costs of treatment.
Transplantation refers to the medical procedure of removing an organ from one body and placing the same in the body of the recipient to replace the failed organ. Multiple organs viz., heart, lung, liver, skin, pancreas, kidney, cornea, can be transplanted. Transplants are essential to lead a healthy life in case of organ and tissue damage. Technological advancements in application and product have led to more successful transplants. The surge has been noticed in tissue transplants with advancements in medical biotechnology. Advanced tissue products such as Dutra matrix Collagen Dura Substitute Membrane and DeNovo NT Graft are beneficial in treatment. Besides, the advanced software and systems allow easy and effective maintenance of tissues. Many companies of different scales are engaged in providing products and services related to transplants. They form alliances for expanding their reach and introduce advanced products to cater to the transplant requirements.
Prevalence of Chronic
Diseases and Organ Failures
The prevalence of chronic and acute diseases eventually leads to organ or tissue failures, requiring transplantation. The critical reasons for organ failure are loss of blood, leukemia, sepsis, drug abuse, severe trauma, among others. Besides, the patients and medical professionals are increasingly adopting transplantation due to its high success rate. In many diseases, as mentioned above, the transplantation gives a new life. New diseases are also being treated with transplants with the advancement of transplant science. The growing incidence of these diseases among large populations ensures the growth of the transplantation market during the projected period.
Transplantation science has witnessed tremendous advancements in the form of 3D Bio-Printing and Biological & mechanical communication. Through these forms, the researchers and scientists are creating human organs and designing artificial limbs, contributing to successful transplantation procedures. The advancements in procurement and preservation of tissues and organs coupled with a rising number of tissue banks have also augmented transplantation services, propelling the growth of the market. Also, the launch of new technological products is expected to enhance the number of transplant procedures for tissues, lungs, kidneys, liver, heart, and lungs.
The Transplantation market is limited by the number of organ donors, organ-matching, and high costs associated with the same. Many transplants require matching of the organs, particularly kidney transplants, which is not attainable in every case. Also, the transplantation market is driven by the availability of organs and organ donors, and the restriction on it leads to impeding the market. Lack of awareness and traditional beliefs prevent organ donations by a large number of people. Besides, the risk of organ rejection also enhances the risk and limits growth.
Impact of COVID-19 in
The economies world over are going the pandemic crisis, leading to shrinkage of production, operations, and availability of various goods & services. The economic activities have been adversely affected due to restrictions on transportation, supply chain disruptions, and distribution network suspensions or delays. Medical professionals are also given guidelines for performing urgent transplantations from the respective medical professional bodies in times of coronavirus spread. They are taking the utmost care while performing surgeries or postponing surgeries as far as possible. However, growing organ failure conditions are expected to need more transplantation.
The Global Transplantation market is segmented into Product Type, Application Type, End-Use, and Region. Based on Product Type, it is again divided into Tissue Products, Immunosuppressive Drugs, and Preservation Solutions. The Tissue product segment is the dominating one with a vital share in revenues and is expected to grow at a substantial CAGR because of the high demand and advancements of the products during the projection period. The rising number of cochlear, orthopedics soft tissues, heart valves, and bone marrow transplantation procedures combined with new product development propel the tissue product demand. The remaining two segments in this category are also anticipated to register moderate growth.
Based on Application Type, the Global Transplantation Market is divided into Organ Transplant and Tissue Transplant. Tissue transplantation accounts for the significant market share of over 60% and, is anticipated to record the highest growth during the projection period due to increasing transplantations of skin, cornea, veins, tendons, bones, heart valves, and nerves. The ever-increasing case of burns and accidents propel the growth of this segment. The organ Transplant segment is also anticipated to grow at a significant rate during the forecast period.
Based on End-user, the market is segregated into Hospitals, Transplant Centers, and Other segments. The hospital segment holds approximately 50% market share and is expected to maintain the same with the rising number of transplantations performed by the hospitals during the projection period. The Transplant Centers are anticipated to witness the highest growth due to the large unmet needs of the patients. The government initiatives promoting organ donation are further expected to induce the transplantation market.
North America Healthcare sector is massively characterized by well-developed healthcare facilities, the use of advanced technology, health-conscious and aware population, substantial expenditure outlay, and major pharmaceutical and healthcare devices manufacturing companies. It is a major market for transplantation and is expected to grow substantially because of the presence of key players and technological advancements. Countries such as Germany, France, UK, and others in the European continent are also expected to witness a rising number of transplants due to their advanced healthcare infrastructure. Asia Pacific is also anticipated to register accelerated CAGR during the projection period on account of growing healthcare infrastructure, awareness about stem cells, and government initiatives in favor of organ donations.
The leading companies in the Transplantation Market include Abbvie, Inc., Arthrex, Inc., Medtronic PLC, Teva Pharmaceuticals, Zimmer Biomet, Strykers, Novartis AG, Veloxis Pharmaceuticals, 21st Century Medicine, BiolifeSolutions, Inc, and others. They are mostly concentrated in developed countries, particularly North America. Many small and medium scale companies are scattered across the globe and operate in the transplantation market. They engage in strategic alliances to strengthen its market position.
July 15, 2020: BioLife Solutions - a leading developer and supplier of
class-defining bioproduction tools (cell and gene therapies), adopts the Evo Cold
Chain Management Platform. The said platform is used for transporting and
monitoring of source material and manufactured doses in more than 100 cell and
gene therapy clinical trials.
June 22, 2020: Transplant Therapeutics Consortium
receives a Letter Of Intent from USFDA for acceptance of the iBox Scoring System into the Center for Drug Evaluation and Research (CDER) -Biomarker Qualification
Program. It will be used as an endpoint in clinical trials of immunosuppressive
drugs meant for transplantation.
Scope of the Report
data – 2016-2019
Base Year –
2020 – 2026
Revenue in USD Billion
U.S, Canada, Germany, UK,
France, Italy, Spain, Brazil, Mexico, Japan, South Korea, China, India, South
Korea UAE, South Africa, Saudi Arabia.
By Product Type, By Application Type, By End-user and By Region.
Abbvie, Inc., Arthrex, Inc., Medtronic PLC, Teva Pharmaceuticals, Zimmer Biomet, Strykers, Novartis AG, Veloxis Pharmaceuticals, 21st Century Medicine, BiolifeSolutions, Inc, and others.
By Product Type
Ø Tissue Products
Ø Immunosuppressive Drugs
Ø Preservation Solution
By Application Type
Ø Organ Transplant
Ø Tissue Transplant
By End User Industry
Ø Transplant Centers
Ø Asia Pacific
Ø North America
Ø Middle East & Africa
Ø Latin America
The objective of the Study:
Ø To analyze and forecast the Global Transplantation market size
of the market, in terms of Value.
Ø To examine the market segmentation carefully and project the
market size, in terms value, based on the region by segmenting the Global Transplantation
market into five regions, namely, North America, Europe, Asia Pacific, Latin
America, Middle East & Africa and their leading countries.
Ø To outline, categorize, and estimate the Global Transplantation market based on the application, product, end-user, and region.
Ø To examine competitive developments in products, applications, and end-user within the Global Transplantation Market.
Ø To highlight the impact analysis of the factors, affecting the
market dynamics such as drivers, restraints, opportunities, and challenges.
Ø To strategically profile the key players and comprehensively
analyze their market shares along with a detailed competitive landscape for
Business Questions Answered by the Report:
Ø How will the market drivers, restraints, and opportunities
affect the market dynamics?
Ø What will be the market size in terms of value and volume and
market statistics with a detailed classification?
Ø Which segment dominates the market or region, and which one will
be the fastest-growing, and why?
Ø Who are the key players in the market, and what is their share?
Ø What is the strategy adopted by key players, and how does it
affect the existing and new players?
Customization Scope for the Client:
Client satisfaction is our first and last priority, and that is
why BlueWeave Consulting offers customization as per the client’s specific needs.
The following customization options are available for the report:
Ø Additional Company Information
Ø Detail Analysis of five additional companies
Ø Additional country analysis
Ø Detailed segment analysis